drugset / Trial / NCT00004998

Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

NCT00004998

Phase 2 Suspended 30 enrolled Agouron Pharmaceuticals
Treatment

Summary

The purpose of this study is to see if two different doses of AG1549 plus other anti-HIV drugs are safe and effective in HIV-infected patients who are not taking anti-HIV drugs.

Timeline

Start
1999-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Capravirine Small molecule
Background Lamivudine Other / unclassified
Background Nelfinavir Other / unclassified
Background Zidovudine Small molecule